Skip to content
Webe Honey – Lifestyle
Author:
Deerfield Group
Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
April 17, 2026
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
April 17, 2026
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
April 9, 2026
Deerfield Group Names Bill Veltre as Chief Media Officer
April 9, 2026
Accent Therapeutics to Present Preclinical Data on Lead Clinical Program, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
April 2, 2026
Petrichor Names Paul Sekhri as Operating Partner
April 1, 2026
Averna Therapeutics Announces Strategic Leadership Expansion
March 26, 2026
GentiBio Announces First Participant Dosed in POLARIS Phase 1 Clinical Trial of GNTI-122 in Recently Diagnosed Type 1 Diabetes
March 18, 2026
←
Previous Page
1
2